Company / Cash per Share
CG Oncology, Inc. Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.42
FY2025
5-year range
$0.42 / $4.11
FY2023-FY2025
Trend
-89.8%
vs FY2024
Sector context
#174 of 204
Health Care
What the data says
CG Oncology, Inc.'s cash per share of $0.42 is lower than 85% of companies in the Health Care sector (FY2025). Declined from $1.91 to $0.42 over the past 2 years.
Based on SEC 10-K filings.
0.42 in FY2025.
Declined from $1.91 to $0.42 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 204This company $0.42 Sector average $73.19
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 89.8% year-over-year.
- Ranks #174 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.42 | -89.8% |
| FY2024 | $4.11 | +115.5% |
| FY2023 | $1.91 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026